Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion type Assertion NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_head.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion description "[Using human tumor and cDNA microarray technology, we have recently shown that the ADAM15 disintegrin is significantly overexpressed during the metastatic progression of human prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_provenance.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion evidence source_evidence_literature NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_provenance.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion SIO_000772 18281484 NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_provenance.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion wasDerivedFrom befree-20140225 NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_provenance.
- NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_assertion wasGeneratedBy ECO_0000203 NP732520.RATB4K-QM0VNWT5Ro2Tq08bf1saBsL_vITvTN-KEUQkhc130_provenance.